Zobrazeno 1 - 10
of 36 935
pro vyhledávání: ''
Autor:
F., Binesh1, A., Hashemi2, M., VaikiI3, M. M., Shakeri4, R., Masoumi Dehshiri2,5 dr.rmasoumi@gmail.com
Publikováno v:
Iranian Journal of Pediatric Hematology & Oncology. 2016, Vol. 6 Issue 1, p15-23. 9p.
Publikováno v:
Current Molecular Medicine. 23:177-184
Aims: This study aimed to evaluate the roles and molecular targets of miRNA-141-3p in the cisplatin sensitivity of osteosarcoma. Background: Osteosarcoma is one of the most common-type bone tumors, occurring mainly in children and adolescents. Cancer
Autor:
Xin Hu, Katharine E. Brock, Karen E. Effinger, Bo Zhang, Ilana Graetz, Joseph Lipscomb, Xu Ji
Publikováno v:
JAMA oncology. 8(11)
ImportanceThe Centers for Disease Control and Prevention (CDC) released an opioid-prescribing guideline in March 2016. Little is known about the guideline’s potential effects on childhood cancer survivors, a population at high risk for pain.Objecti
Autor:
Leena Chehab, David R. Doody, Adam J. Esbenshade, Gregory M.T. Guilcher, Christopher C. Dvorak, Brian T. Fisher, Beth A. Mueller, Eric J. Chow, Jenna Rossoff
Publikováno v:
Journal of Clinical Oncology. 41:364-372
PURPOSE Infections pose a significant risk during therapy for childhood cancer. However, little is known about the risk of infection in long-term survivors of childhood cancer. METHODS We performed a retrospective observational study of children and
Autor:
Liora M. Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating, Christa Krupski, Holly Pacenta, Christine L. Philips, Julie-An Talano, Amy Moskop, Susanne H.C. Baumeister, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Sharon Mavroukakis, Emily Egeler, Yimei Li, Crystal L. Mackall, Kevin J. Curran, Michael R. Verneris, Theodore W. Laetsch, Heather Stefanski
Publikováno v:
Journal of Clinical Oncology. 41:354-363
PURPOSE Nonresponse and relapse after CD19-chimeric antigen receptor (CAR) T-cell therapy continue to challenge survival outcomes. Phase II landmark data from the ELIANA trial demonstrated nonresponse and relapse rates of 14.5% and 28%, respectively,
Autor:
Fornecker, Luc-Matthieu, Lazarovici, Julien, Aurer, Igor, Casasnovas, René-Olivier, Gac, Anne-Claire, Bonnet, Christophe, Bouabdallah, Krimo, Feugier, Pierre, Specht, Lena, Molina, Lysiane, Touati, Mohamed, Borel, Cécile, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Pascal, Laurent, Lugtenburg, Pieternella, Di Renzo, Nicola, Vander Borght, Thierry, Traverse-Glehen, Alexandra, Dartigues, Peggy, Hutchings, Martin, Versari, Annibale, Meignan, Michel, Federico, Massimo, André, Marc, LYSA-FIL-EORTC Intergroup
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(2), 327-335. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, no. 2, p. 327-335 (2022)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, no. 2, p. 327-335 (2022)
PURPOSE The prognosis of patients with early-stage unfavorable Hodgkin lymphoma remains unsatisfactory. We assessed the efficacy and safety of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (BV-AVD) in previously untreated, early-
Autor:
Marie Morfouace, Peter Horak, Simon Kreutzfeldt, Aleksandra Stevovic, Teresa de Rojas, Evgeniya Denisova, Barbara Hutter, Francisco Bautista, Júlio Oliveira, Anne-Sophie Defachelles, Jeff White, Bernd Kasper, Matthias Preusser, Vassilis Golfinopoulos, Stefan Pfister, Winette Van der Graaf, Eva Wardelmann, Patrick Shenjere, Stefan Fröhling, Martin G. McCabe
Publikováno v:
European Journal of Cancer, 178, 216-226. Elsevier Ltd.
Background: Adolescent and young adult (AYA) patients with cancer are poorly recruited to molecularly targeted trials and have not witnessed the advances in cancer treatment and survival seen in other age groups. We report here a pan-European proof-o
Autor:
Rudà, Roberta, Capper, David, Waldman, Adam D, Pallud, Johan, Minniti, Giuseppe, Kaley, Thomas J, Bouffet, Eric, Tabatabai, Ghazaleh, Aronica, Eleonora, Jakola, Asgeir S, Pfister, Stefan M, Schiff, David, Lassman, Andrew B, Solomon, David A, Soffietti, Riccardo, Weller, Michael, Preusser, Matthias, Idbaih, Ahmed, Wen, Patrick Y, van den Bent, Martin J
Publikováno v:
Neuro-Oncology, 24(12), 2015-2034. Oxford University Press
Neuro-oncology, 24(12), 2015-2034. Oxford University Press
Rudà, R, Capper, D, Waldman, A D, Pallud, J, Minniti, G, Kaley, T J, Bouffet, E, Tabatabai, G, Aronica, E, Jakola, A S, Pfister, S M, Schiff, D, Lassman, A B, Solomon, D A, Soffietti, R, Weller, M, Preusser, M, Idbaih, A, Wen, P Y & van den Bent, M J 2022, ' EANO-EURACAN-SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors ', Neuro-Oncology, vol. 24, no. 12, pp. 2015-2034 . https://doi.org/10.1093/neuonc/noac188
Neuro-oncology, 24(12), 2015-2034. Oxford University Press
Rudà, R, Capper, D, Waldman, A D, Pallud, J, Minniti, G, Kaley, T J, Bouffet, E, Tabatabai, G, Aronica, E, Jakola, A S, Pfister, S M, Schiff, D, Lassman, A B, Solomon, D A, Soffietti, R, Weller, M, Preusser, M, Idbaih, A, Wen, P Y & van den Bent, M J 2022, ' EANO-EURACAN-SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors ', Neuro-Oncology, vol. 24, no. 12, pp. 2015-2034 . https://doi.org/10.1093/neuonc/noac188
In the new WHO 2021 Classification of CNS Tumors the chapter “Circumscribed astrocytic gliomas, glioneuronal and neuronal tumors” encompasses several different rare tumor entities, which occur more frequently in children, adolescents, and young a
Autor:
Andrés Gómez-De León, Ana L. Varela-Constantino, Perla R. Colunga-Pedraza, Alexia Sánchez-Arteaga, Valeria García-Zárate, Anna Cecilia Rodríguez-Zúñiga, Nereida Méndez-Ramírez, Olga G. Cantú-Rodríguez, César H. Gutiérrez-Aguirre, Luz Tarín-Arzaga, Elías E. González-López, José Carlos Jaime-Pérez, David Gómez-Almaguer
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:883-893
B-cell acute lymphoblastic leukemia is frequent in Hispanic adolescents and young adults. Outcomes of implementation of pediatric-inspired regimens in low-and middle-income countries are not well known.In this study we treated 94 adolescents and youn
Autor:
Josien C. A. Jenniskens, Kelly Offermans, Colinda C. J. M. Simons, Iryna Samarska, Gregorio E. Fazzi, Jaleesa R. M. van der Meer, Kim M. Smits, Leo J. Schouten, Matty P. Weijenberg, Heike I. Grabsch, Piet A. van den Brandt
Publikováno v:
Molecular Carcinogenesis, 61(12), 1099-1115. Wiley-Liss Inc.
KRAS mutations (KRASmut ), PIK3CAmut , BRAFmut , and deficient DNA mismatch repair (dMMR) have been associated with the Warburg effect. We previously reported differential associations between early-life energy balance-related factors (height, energy